Monday, October 5, 2026

Exodus Volume Down 26% in Q1 as Banks and AI-Native Fintechs Accelerate Machine Learning Deployment

Exodus Movement reported $1.18 billion in exchange volume for Q1 2026, down 26% from Q4 2025, while funded users fell 18% to 1.4 million. Net losses widened 149% year-over-year to $32.1 million. The retail crypto contraction is occurring in parallel with aggressive AI infrastructure deployment by institutional banks and AI-native fintech firms.

LM Salvado

May 12, 2026

Exodus Volume Down 26% in Q1 as Banks and AI-Native Fintechs Accelerate Machine Learning Deployment
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Retail crypto is losing ground while institutional AI deployment accelerates. Exodus Movement's exchange volume fell to $1.18 billion in Q1 2026, down 26% from Q4 2025, as funded users dropped 18% to 1.4 million from 1.7 million at year-end.1

Losses widened sharply. Net loss reached $32.1 million in Q1 2026 versus $12.9 million a year earlier — a 149% year-over-year increase.1 Bitcoin led trading at 29% of volume. Tether on the TRX network followed at 14%, Tether on ETH at 11%, ETH at 9%, and USDC at 7%.1

The retail pullback is running parallel to accelerating institutional AI adoption. MoneySkills launched an AI-powered quantitative trading environment built around structured market analysis and disciplined decision-making.2 The platform focuses on systematic information collection, quantitative signal interpretation, risk visualization, and structured decision formulation — targeting the elimination of emotional interference in trade execution.2

The logic underpinning the platform reflects a broader institutional thesis: quality trading is determined before the trade, not during it. AI infrastructure handles systematic data processing; human judgment is reserved for higher-order decisions. That framing is now standard across institutional deployments.

Major banks and fintech firms are applying the same architecture at scale. Tokenized deposits, AI-assisted loan origination, and agent-enabled service delivery are moving from pilots to production. Machine learning is no longer a peripheral feature of institutional finance — it is becoming the operational layer.

Crypto exchange consolidation reinforces the maturation dynamic. Scale is a survival requirement in exchange markets. Smaller retail platforms face compounding pressure: user attrition, rising losses, and the capital requirements to compete on infrastructure. The Kraken-Gemini integration reflects this dynamic — consolidation driven by scale economics, not strategic optionality.

For institutional players, AI is becoming the primary operational differentiator. The advantage accrues to those who can deploy, iterate, and scale ML systems fastest. AI-native fintech startups are competing directly with legacy banks on infrastructure — and banks are responding with accelerated technology investment rather than ceding ground.

The numbers now make the split explicit. Retail-facing crypto platforms are contracting on volume, users, and profitability simultaneously. Institutional AI deployment is expanding. The fintech map is being redrawn around AI infrastructure, and the rotation is structural, not cyclical.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score12 source documents12 with a live linkVerifiability: Strong
  1. [1]Press releaseGlobeNewswire· May 11, 2026
    Exodus Reports First Quarter 2026 Results
  2. [2]Press releaseGlobeNewswire· May 11, 2026
    Money Skills Launches AI-Powered Quantitative Trading Environment, Focusing on Structured Market Analysis and Disciplined Decision-Making
  3. [3]News articleCrunchbase News
    5 Interesting Startup Deals You May Have Missed: A Credit Card Backed By Mineral Rights, Flying Ferries, And A Foundation AI Model For Plants
  4. [4]News articleYahoo Finance· March 23, 2026
    Buy 3 Giant Mobile Payments Stocks With Solid Short-Term Price Upside
  5. [5]Press releaseGlobeNewswire· April 24, 2026
    Flow Traders 1Q 2026 Trading Update
  6. [6]News articleYahoo Finance· March 27, 2026
    How The Investment Story For Bank Of Montreal (TSX:BMO) Is Quietly Shifting After Q1
  7. [7]Press releaseGlobeNewswire· April 14, 2026
    NeuroTrader Launches AI Crypto Trading Platform With Free Entry and Five Subscription Tiers
  8. [8]Press releaseGlobeNewswire· April 4, 2026
    New platform Suomi-kasinot.fi launches to simplify online casino choices for Finnish players
  9. [9]News articleSeeking Alpha· April 27, 2026
    Norwood Financial anticipates $2.2M in 2026 margin accretion while integrating Presence Bank
  10. [10]News articleSeeking Alpha· April 17, 2026
    Regions projects 2026 net interest income growth of 2.5%-4% with net interest margin exiting in the low 3.70%s
  11. [11]News articleYahoo Finance· April 19, 2026
    STT Q1 Deep Dive: Fee Revenue, Digital Innovation, and AI Transformation Propel Results
  12. [12]News articleCrunchbase News
    The Week’s 10 Biggest Funding Rounds: Enterprise AI, Space Tech And Biotech Top The Ranks

In this story

LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com